Immune-mediated adverse events following influenza vaccine in cancer patients receiving immune checkpoint inhibitors.

Gwynn, Morgan E; DeRemer, David L; Saunders, Katherine M; Parikh, Jigarkumar; Bollag, Roni J; Clemmons, Amber B

Gwynn, Morgan E; DeRemer, David L; Saunders, Katherine M; Parikh, Jigarkumar; Bollag, Roni J; Clemmons, Amber B.

Afiliación

Gwynn ME; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA.
DeRemer DL; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Saunders KM; Department of Pharmacy, Augusta University Medical Center, Augusta, GA, USA.
Parikh J; Georgia Cancer Center, Augusta, GA, USA.
Bollag RJ; Georgia Cancer Center, Augusta, GA, USA.
Clemmons AB; Department of Hematology/Oncology, Augusta University, Augusta, GA, USA.

J Oncol Pharm Pract ; 26(3): 647-654, 2020 Apr.

Article en En | MEDLINE | ID: mdl-31474214

Asunto(s)

Vacunas contra la Influenza/efectos adversos; Neoplasias/inmunología; Receptor de Muerte Celular Programada 1/antagonistas & inhibidores; Vacunación/efectos adversos; Adulto; Anciano; Anciano de 80 o más Años; Citocinas/sangre; Femenino; Humanos; Masculino; Persona de Mediana Edad; Neoplasias/tratamiento farmacológico; Estudios Prospectivos

Palabras clave

Adverse events; immune checkpoint inhibitors; influenza vaccine; pd-1 inhibitor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Vacunación / Receptor de Muerte Celular Programada 1 / Neoplasias Tipo de estudio: Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Oncol Pharm Pract Asunto de la revista: FARMACIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google